Collaboration partners and funding sources

Heggebø LC, Borgen IMH, Blakstad H, Saxhaug C, Rønning PA, Niehusmann PF, Werlenius K, Blomstrand M, Brandal P (2025)
Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
Front Oncol, 15, 1397912
DOI 10.3389/fonc.2025.1397912, PubMed 39949738

Liu Q, Fuster-Garcia E, Hovden IT, MacIntosh BJ, Grodem EOS, Brandal P, Lopez-Mateu C, Sederevicius D, Skogen K, Schellhorn T, Bjornerud A, Emblem KE (2025)
Treatment-aware Diffusion Probabilistic Model for Longitudinal MRI Generation and Diffuse Glioma Growth Prediction
IEEE Trans Med Imaging, PP (in press)
DOI 10.1109/TMI.2025.3533038, PubMed 40031286

Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P (2024)
The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
J Neurooncol, 169 (1), 137-145
DOI 10.1007/s11060-024-04709-z, PubMed 38762830